The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

(2013) S. Gierer et al.   JOURNAL OF VIROLOGY

Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection

(2013) Charles J. Shoemaker et al.   PLoS One

Prolactin stimulates the L-type calcium channel-mediated transepithelial calcium transport in the duodenum of male rats

(2012) Nitita Dorkkam et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever

(2012) Judith van Paassen et al.   LANCET INFECTIOUS DISEASES

Hepatitis C virus host cell entry

(2012) Alexander Ploss et al.   Current Opinion in Virology

Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype

(2011) Elena Piccoli et al.   BIOCHEMICAL PHARMACOLOGY

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

(2011) Sandra Ciesek et al.   HEPATOLOGY

Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles

(2011) S. Ciesek et al.   JOURNAL OF VIROLOGY

Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection

(2011) Marceline Côté et al.   NATURE

Ebola virus entry requires the cholesterol transporter Niemann–Pick C1

(2011) Jan E. Carette et al.   NATURE

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

(2011) Joachim Lupberger et al.   NATURE MEDICINE

T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus

(2011) A. S. Kondratowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway

(2011) Nirupama Mulherkar et al.   VIROLOGY

Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus

(2011) Mohammad F. Saeed et al.   PLoS Pathogens

Viral Drug Sensitivity Testing Using Quantitative PCR: Table 1

(2010) Parmjeet S. Randhawa et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

(2010) Thomas W Geisbert et al.   LANCET

Ebola haemorrhagic fever

(2010) Heinz Feldmann et al.   LANCET

Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner

(2010) Asuka Nanbo et al.   PLoS Pathogens

Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A

(2009) Sandra Ciesek et al.   HEPATOLOGY

Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level

(2008) Konrad Stadler et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Isolation of Primary Human Hepatocytes After Partial Hepatectomy: Criteria for Identification of the Most Promising Liver Specimen

(2008) Florian Wolfgang Rudolf Vondran et al.   ARTIFICIAL ORGANS

Cell entry by human pathogenic arenaviruses

(2008) Jillian M. Rojek et al.   CELLULAR MICROBIOLOGY

Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates

(2008) T. W. Geisbert et al.   JOURNAL OF VIROLOGY

Different Mechanisms of Cell Entry by Human-Pathogenic Old World and New World Arenaviruses

(2008) J. M. Rojek et al.   JOURNAL OF VIROLOGY

Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure−Property−Activity Relation Model

(2007) Johannes Kornhuber et al.   JOURNAL OF MEDICINAL CHEMISTRY